EGFR and non-small cell lung carcinoma: In a study that assessed the prevalence of EGFR mutations in patients with non-squamous NSCLC in Lubelskie and Wielkopolskie voivodeships, the frequency of testing for these mutations was estimated to be approximately 40% in 2011–2012 [40].